PR Newswire
- Chenghe Acquisition II Co. Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on July 29, 2024 26/07/2024SINGAPORE, July 27, 2024 /PRNewswire/ -- Chenghe Acquisition II Co. (the "Company") today announced that, commencing on July 29, 2024, holders of the units (the "Units") sold in the Company's initial public offering may elect to separately trade the Company's Class A Ordinary Shares (the "Shares") and warrants (the "Warrants") included in the Units. The […]
- Mega Matrix announced that FlexTV App achieved the new milestone, surging into Top 8 on the Apple Store Entertainment Chart (Free Apps, Japan) as of July 26, 2024 26/07/2024PALO ALTO, Calif., July 27, 2024 /PRNewswire/ -- Mega Matrix Corp. ("MPU" or the "Company") (NYSE American: MPU), today announced that FlexTV, its short drama streaming platform, surged into No.8. in the App Store Entertainment Apps (Free Apps, Japan) as of July 26, 2024. FlexTV continues to excel in the Asian market! Following its 2nd […]
- vivo Unveils Future Imaging Trends and Announces Winners of VISION+ Mobile PhotoAwards 2024 26/07/2024XINING, China, July 27, 2024 /PRNewswire/ -- vivo today held the 2024 vivo Imaging Conference in Xining, China, where it showcased vivo's latest advancements in imaging technologies. The company presented its progressive strategies surrounding three new trends in mobile imaging: imaging security, 3D imaging/XR and health imaging. In addition, the results of the VISION+ Mobile PhotoAwards […]
- Pierre Fabre Laboratories receives CHMP positive opinion for BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with a BRAFV600E mutation 26/07/2024The positive CHMP opinion is based on results from the Phase II PHAROS trial,[1] which demonstrated an objective response rate (ORR) of 75% in treatment-naïve patients and 46% in previously treated patients. The safety profile is consistent with that observed in the approved metastatic melanoma indication[1] The European Commission decision for BRAFTOVI® (encorafenib) + MEKTOVI® (binimetinib) is expected […]
- Warner Bros. World™ Yas Island, Abu Dhabi soars to new heights with Etihad Airways partnership 26/07/2024ABU DHABI, UAE, July 26, 2024 /PRNewswire/ -- Warner Bros. World™ Yas Island, Abu Dhabi, the region's largest indoor theme park, is thrilled to announce a groundbreaking extension to its partnership with Etihad Airways, marking a monumental milestone in its history. This exciting collaboration was unveiled to the public on July 25 at a spectacular […]
- MHX Jakarta 18-21 July 2024 Wrapped Up with Record Turnout, High Leads Generation and Strategic Partnerships 26/07/2024JAKARTA, Indonesia, July 26, 2024 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC) achieved impressive results in numerous fronts in Jakarta! MHTC is the pioneer in organising healthcare expo in Indonesia and the inaugural event was in Semarang in 2012. MHTC has successfully organised two events in Indonesia in the first half of 2024, and the […]
- Azazie Unveils Fashion Forward Atelier Collection - "Secret Garden" 26/07/2024LOS ANGELES, July 26, 2024 /PRNewswire/ -- Azazie, the leading DTC e-tailer for all things bridal and occasion wear, is thrilled to announce the launch of its latest collection, "Secret Garden," under the exclusive Atelier line. This new collection draws inspiration from the enchanting beauty of a hidden garden, featuring ethereal designs and intricate details […]
- ReviR Therapeutics Raises $30 Million Series A Financing to Advance its Proprietary Oral Genetic Medicines for Multiple CNS Disorders 26/07/2024BRISBANE, Calif., July 26, 2024 /PRNewswire/ -- ReviR Therapeutics, an AI-enabled biotechnology company focused on developing small molecule RNA modulators for neurogenetic diseases, announced today that it has successfully completed a $30 million Series A financing, bringing the total raised so far to $54M, including the seed financing in 2021. The financing was led by […]
- WiMi Built an Advanced Data Structure Architecture Using Homomorphic Encryption and Federated Learning 26/07/2024BEIJING, July 26, 2024 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it utilized homomorphic encryption and federated learning building an advanced data structure architecture. The architecture integrates federated learning and partial homomorphic encryption, and this integration protects data […]
- Hisense Ignites Sporting Passion with Big Screen Viewing from Paris 26/07/2024QINGDAO, China, July 26, 2024 /PRNewswire/ -- As the world's biggest sporting occasion gets underway, Hisense, a global leader in consumer electronics and appliances is igniting sporting passions direct from Paris with its 'Big Game, Big Screen' campaign. Hisense ignites sporting passion with ‘Big Game, Big Screen’ campaign Highlight of Hisense's ongoing global promotional campaign is […]
- Xinhua Silk Road: NE. China's Harbin becomes popular summer tourism destination with rich wetland resources 26/07/2024BEIJING, July 26, 2024 /PRNewswire/ -- Boasting rich wetland resources, Harbin City in northeast China's Heilongjiang Province has become a popular tourism destination in summer days this year. Photo shows the Hulan River estuary wetland park in Harbin City, northeast China's Heilongjiang Province. (Xinhua/Zhu Yue) Since the start of July, the search volume for "wetlands" […]
- CStone Announces European Commission Approval of Sugemalimab (Cejemly®) as First-Line Treatment for Non-Small Cell Lung Cancer 26/07/2024Sugemalimab becomes the world's first anti-PD-L1 monoclonal antibody (mAb) approved in Europe for first-line treatment of both squamous and non-squamous non-small cell lung cancer (NSCLC), also marking the first successful international approval of a China domestic anti-PD-L1 mAb. The European Commission (EC) approval is based on the results of GEMSTONE-302 Phase 3 trial, which demonstrated […]
- Nature's Miracle Holding Inc. Announces Pricing of $1.2 Million Public Offering 26/07/2024ONTARIO, Calif., July 26, 2024 /PRNewswire/ -- Nature's Miracle Holding Inc. (NASDAQ: NMHI) ("Nature's Miracle" or the "Company"), a leader in vertical farming technology and infrastructure, today announced the pricing of a public offering of 5,000,000 units (the "Units") consisting of (i) one share of common stock, par value $ 0.0001 per share ("Common Stock") and […]
- CougarD Soars with 115% User Surge: New Video Verification Feature Drives Unprecedented Growth 26/07/2024WASHINGTON, July 26, 2024 /PRNewswire/ -- CougarD, a leading innovator in mature dating, is delighted to announce its outstanding performance for the first half of 2024. The company has achieved significant milestones, including a 115% increase in user registrations and a 91% rise in paid subscriptions, driven by the successful implementation of its new video verification […]
- MGI and HKBU Collaborate on Advanced Sequencing Technology to Combat Doping in Sports 26/07/2024PARIS, July 26, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, today announced its collaboration with renowned geneticist, Professor Yannis Pitsiladis from Hong Kong Baptist University, on sports and anti-doping research. Utilizing MGI's state-of-the-art DNBSEQ sequencers and automation platforms, the […]
- HanAll Biopharma Reports Q2 2024 Financial Results and Provides Business Update 26/07/2024HanAll reports strong financial performance with second quarter total revenue of 31.6 billion KRW, driven by the strong sales from the key products. HanAll expands collaboration with Turn Biotechnologies through an exclusive licensing agreement for Epigenetic Reprogramming of Aging (ERATM) technology, targeting ophthalmic and otic diseases. Progress in clinical development programs continued including the completion […]
- 2024 CICC GBA Wealth Management Forum successfully held in Hong Kong 26/07/2024BEIJING, July 26, 2024 /PRNewswire/ -- On 25th July, China International Capital Corporation Limited (CICC) successfully held the 2024 CICC GBA Wealth Management Forum in Hong Kong. Themed "Developing New Quality Productive Forces, Driving New Momentum in Wealth", the forum gathered a multitude of distinguished representatives from various sectors within the Guangdong-Hong Kong-Macao Greater Bay Area […]
- GMIF2024 Innovation Summit Invites All to Gather in Shenzhen on September 27 26/07/2024SHENZHEN, China, July 26, 2024 /PRNewswire/ -- Driven by production cuts and price increases from upstream manufacturers, alongside a gradual revival in the consumer electronics market, the memory industry is witnessing a recovery after two years of supply-demand imbalance and significant price declines, and behind it also hides a new trend in the industry fueled […]
- BRI Prudent Strategy Yields IDR29.90 Trillion Profit in Q2 2024 26/07/2024JAKARTA, Indonesia, July 26, 2024 /PRNewswire/ -- Bank Rakyat Indonesia (Persero) Tbk (IDX: BBRI) and its subsidiaries, BRI Group, reported a profit of IDR 29.90 trillion in the Second Quarter of 2024, achieved through selective and prudent growth. This was announced by BRI President Director, Sunarso, during the Q2 2024 financial performance press conference on […]
- Global X US Treasury 3-5 Year ETF Hits US$100 Million Milestone in AUM, Ranked as The Largest US Treasury ETF Listed in Hong Kong 26/07/2024HONG KONG, July 26, 2024 /PRNewswire/ -- Mirae Asset Global Investments (Hong Kong) Limited, (the "Firm" or "Mirae Asset") is delighted to celebrate that the Global X US Treasury 3-5 Year ETF (3450) has surpassed US$100 million in AUM, marking it a significant achievement within just a few weeks since its launch in July this year. The […]